Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Related Articles by Review for PubMed (Select 15146413)

2.

Macrophage migration inhibitory factor in rheumatoid arthritis.

Morand EF, Leech M.

Front Biosci. 2005 Jan 1;10:12-22. Review.

PMID:
15576336
3.
4.

Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.

Volin MV, Koch AE.

J Interferon Cytokine Res. 2011 Oct;31(10):745-51. doi: 10.1089/jir.2011.0050. Epub 2011 Aug 24. Review.

PMID:
21864160
5.

[In vitro and in vivo study of regulation mechanisms of type I interleukin-1 receptor].

Takii T.

Yakugaku Zasshi. 2001 Jan;121(1):9-21. Review. Japanese.

6.
7.

Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.

Jue DM, Jeon KI, Jeong JY.

J Korean Med Sci. 1999 Jun;14(3):231-8. Review.

9.

[The study on the interleukin-8 (IL-8)].

Zhang W, Chen H.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2002 Dec;19(4):697-702. Review. Chinese.

PMID:
12561382
10.

The effect of interleukin-1 on connective tissue metabolism and its relevance to arthritis.

Bunning RA, Richardson HJ, Crawford A, Skjodt H, Hughes D, Evans DB, Gowen M, Dobson PR, Brown BL, Russell RG.

Agents Actions Suppl. 1986;18:131-52. Review.

PMID:
3524146
11.

Pathophysiological roles for IL-18 in inflammatory arthritis.

Matsui K, Tsutsui H, Nakanishi K.

Expert Opin Ther Targets. 2003 Dec;7(6):701-24. Review.

PMID:
14640907
12.

Cytokines in rheumatoid arthritis.

Vervoordeldonk MJ, Tak PP.

Curr Rheumatol Rep. 2002 Jun;4(3):208-17. Review.

PMID:
12010605
13.

Effects of DMARDs on IL-1Ra levels in rheumatoid arthritis: is there any evidence?

Cutolo M.

Clin Exp Rheumatol. 2002 Sep-Oct;20(5 Suppl 27):S26-31. Review.

PMID:
14989426
15.

[Molecular mechanism of interleukin-8 gene expression].

Mukaida N, Murayama T.

Rinsho Byori. 1998 Aug;46(8):821-8. Review. Japanese.

PMID:
9760836
16.

Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.

Orita M, Yamamoto S, Katayama N, Fujita S.

Curr Pharm Des. 2002;8(14):1297-317. Review.

PMID:
12052220
17.

Rho GTPases as therapeutic targets for the treatment of inflammatory diseases.

Zhao D, Pothoulakis C.

Expert Opin Ther Targets. 2003 Oct;7(5):583-92. Review.

PMID:
14498821
18.

Control of p53 and NF-κB signaling by WIP1 and MIF: role in cellular senescence and organismal aging.

Salminen A, Kaarniranta K.

Cell Signal. 2011 May;23(5):747-52. doi: 10.1016/j.cellsig.2010.10.012. Epub 2010 Oct 16. Review.

PMID:
20940041
19.

Pathogenesis of joint destruction in rheumatoid arthritis.

Shiozawa S, Tsumiyama K, Yoshida K, Hashiramoto A.

Arch Immunol Ther Exp (Warsz). 2011 Apr;59(2):89-95. doi: 10.1007/s00005-011-0116-3. Epub 2011 Feb 16. Review.

PMID:
21327737
20.

[Molecular mechanisms of action of gold in treatment of rheumatoid arthritis--an update].

Burmester GR.

Z Rheumatol. 2001 Jun;60(3):167-73. Review. German.

PMID:
11475604
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk